Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin M Bednar

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Expert Opinion on Pharmacotherapy|April 6, 2002
Combining antiplatelet and thrombolytic therapies for strokeMartin M Bednar
Progress in Molecular Biology and Translational Science|November 9, 2019
Combination therapy for Alzheimer's disease and related dementiasMartin M Bednar
Current Opinion in Investigational Drugs (London, England : 2000)|July 5, 2008
The role of sildenafil in the treatment of strokeMartin M Bednar
Idrugs : the Investigational Drugs Journal|August 22, 2009
Anti-amyloid antibody drugs in clinical testing for Alzheimer's diseaseMartin M Bednar
Neurological Research|September 2, 2006
Interventions for heart disease and their effects on Alzheimer's diseaseBenjamin Wolozin, Martin M Bednar
Neurological Research|February 16, 2012
Neurorestoration therapeutics for neurodegenerative and psychiatric diseaseMartin M Bednar, Ann Perry
Journal of Alzheimer'S Disease : JAD|September 23, 2010
Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesiaTara Vanderweyde, Martin M Bednar, Stuart A Forman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitorPeter J Snyder, Martin M Bednar, Jennifer R Cromer, et al.
Journal of Alzheimer'S Disease : JAD|September 1, 2005
Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplastyTodd A Lee, Benjamin Wolozin, Kevin B Weiss, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 8, 2016
Phosphodiesterase-5 Inhibitor PF-03049423 Effect on Stroke Recovery: A Double-Blind, Placebo-Controlled Randomized Clinical TrialFranco Di Cesare, Jessica Mancuso, Phil Woodward, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|April 6, 2002
Combining antiplatelet and thrombolytic therapies for strokeMartin M Bednar
Progress in Molecular Biology and Translational Science|November 9, 2019
Combination therapy for Alzheimer's disease and related dementiasMartin M Bednar
Current Opinion in Investigational Drugs (London, England : 2000)|July 5, 2008
The role of sildenafil in the treatment of strokeMartin M Bednar
Idrugs : the Investigational Drugs Journal|August 22, 2009
Anti-amyloid antibody drugs in clinical testing for Alzheimer's diseaseMartin M Bednar
Neurological Research|September 2, 2006
Interventions for heart disease and their effects on Alzheimer's diseaseBenjamin Wolozin, Martin M Bednar
Neurological Research|February 16, 2012
Neurorestoration therapeutics for neurodegenerative and psychiatric diseaseMartin M Bednar, Ann Perry
Journal of Alzheimer'S Disease : JAD|September 23, 2010
Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesiaTara Vanderweyde, Martin M Bednar, Stuart A Forman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitorPeter J Snyder, Martin M Bednar, Jennifer R Cromer, et al.
Journal of Alzheimer'S Disease : JAD|September 1, 2005
Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplastyTodd A Lee, Benjamin Wolozin, Kevin B Weiss, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 8, 2016
Phosphodiesterase-5 Inhibitor PF-03049423 Effect on Stroke Recovery: A Double-Blind, Placebo-Controlled Randomized Clinical TrialFranco Di Cesare, Jessica Mancuso, Phil Woodward, et al.
Pageof 3